Insulin-like growth factor binding protein (IGFBP)-3 effects proliferation and differentiation of numerous cell types by binding to insulin-like growth factors (IGF) and attenuating their activity or by directly affecting cells in an IGFindependent manner. Consequently, IGFBPs produced by specific c
Stimulatory effect of a phorbol ester on expression of insulin-like growth factor (IGF) binding protein-2 and level of IGF-I receptors in mouse osteoblastic MC3T3-E1 cells
✍ Scribed by Yoshiyuki Hakeda; Kenji Yoshizawa; Marja Hurley; Hiroshi Kawaguchi; Ken-Ichi Tezuka; Kayo Tanaka; Takuya Satoh; Masayoshi Kumegawa
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 776 KB
- Volume
- 158
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We examined the relationship between signal transduction and the expression of insulin‐like growth factor I (IGF‐I), IGF‐I receptor level, and IGF binding proteins (IGFBPs) in murine clonal osteoblastic MC3T3‐E1 cells. 12–O‐Tetradecanoylphorbol‐13‐acetate (TPA), an activator of protein kinase C, decreased the secretion of immunoreactive IGF‐I into the medium, whereas dibutyryl cAMP (Bt~2~cAMP) augmented the secretion In contrast, TPA increased the level of type IIGF receptor on the cells. Furthermore, MC3T3‐E1 cells produced and secreted at least three different IGFBPs with molecular masses of 24, 30, and 34 kDa, and the 24‐kDa IGFBP was predominant under normal conditions. However, TPA specifically increased the secretion of the 34‐kDa IGFBP. The N‐terminal amino acid sequence of the purified 34‐kDa IGFBP was nearly identical with that of rat IGFBP‐2. Furthermore, the 34‐kDa IGFBP was immunoreactive to anti‐IGFBP‐2 antiserum. The level of IGFBP‐2 mRNA in the cells was increased by TPA, indicating that the increase in IGFBP‐2 secretion results from the stimulation of IGFBP‐2 production. In contrast, Bt~2~cAMP affected neither IGF‐l receptor number nor the IGFBP secretion. These results indicate that the production of IGF‐l and the expression of IGF‐l receptors and IGFBP‐2 are up‐regulated by the activation of adenylate cyclase and protein kinase C, respectively, in osteoblastic MC3T3‐E1 cells. © 1994 Willey‐Liss, Inc.
📜 SIMILAR VOLUMES
Insulin-like growth factor-I (IGF-I) has mitogenic and anti-apoptotic properties and has been implicated in the development of breast, colorectum, prostate and lung cancer. IGF binding proteins (IGFBPs) are not only carrier proteins for IGFs but also hold a central position in IGF ligand-receptor in
## Abstract Bone metastases from prostate cancer cause abnormal new bone formation, however, the factors involved and the pathways leading to the response are incompletely defined. We investigated the mechanisms of osteoblast stimulatory effects of LNCaP prostate carcinoma cell conditioned media (C
## Abstract Insulin‐like growth factor 1 (IGF‐1) and its major binding protein, IGF binding protein 3 (IGFBP‐3) are implicated in lung cancer and other malignancies. We have previously shown that the combination of three major antioxidants [β‐carotene (BC), α‐tocopherol (AT) and ascorbic acid (AA)]